Table 4 Bivariate and multivariable Analysis to identify determinants of dilated cardiomyopathy in patients with thyrotoxicosis at the endocrine clinic, ACSH from December, 2017 to June, 2018
From: Thyrotoxicosis and dilated cardiomyopathy in developing countries
Variables /Categories | COR (95 % CI) | P value | AOR (95 % CI) | P value |
|---|---|---|---|---|
Age (in years) | ||||
≤ 40 | 1 | 1 | ||
> 40 | 2.46 (1.16–5.24) | 0.019 | 0.72 (0.27–1.95) | 0.523 |
Level of free T4 (Pmol/L) | ||||
≤ 60 | 1 | 1 | ||
> 60 | 2.99 (1.39–6.41) | 0.005 | 0.67 (0.25–1.80) | 0.436 |
Atrial fibrillation | ||||
Yes | 20.42 (8.45–49.31) | 0.001 | 15.95 (5.89–38.16) | 0.001 |
No | 1 | 1 | ||
Tachycardia | ||||
Yes | 5.48 (2.49–12.01) | 0.001 | 2.73 (1.04–7.15) | 0.040 |
No | 1 | 1 | ||